U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07267949) titled 'Clinical Randomised Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation' on Nov. 25.
Brief Summary: A clinical Randomized Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation.
Study Start Date: Oct. 22
Study Type: INTERVENTIONAL
Condition:
Atrial Fibrillation (AF)
Intervention:
DRUG: AP31969
Tablets, Oral, Twice daily.
DRUG: Placebo
Tablets, oral, Twice daily.
Recruitment Status: RECRUITING
Sponsor: Acesion Pharma
Disclaimer: Curated by HT Syndication....